Maury Raycroft

Q: What is Maury Raycroft's success rate?

Maury Raycroft currently has a success rate of 76.39594750986414.

Q: What is the average return of Maury Raycroft's calls?

Their stock ratings have generated an average return of 56.771233587933935.

Jefferies | Healthcare

Maury Raycroft is an analyst from Jefferies specializing in the Healthcare sector. Ranked #334 out of 4496 analysts, they have issued 12 stock ratings with a success rate of 76.40% and an average return of 56.77%.

With 12 ratings to date, Maury Raycroft is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 76.40% and an average return of 56.77%, highlighting promising potential as their track record develops further.

#334

Out of 4496

Total Ratings

+76.40%

Success Rate

+56.77%

Average Return

Recent Ratings Analysis

MREO

Hold

Dec 30, 2025

Target

$7.00

Current

$0.37

Performance

0.00%

Maury Raycroft rated MREO as Hold on Dec 30, 2025, setting a price target of 7. The Hold stance appears justified, as shares hovered around 0.3705 with a 0.00% move.

CELC

Buy

Dec 02, 2025

Target

$134.00

Current

$99.92

Performance

2.48%

On Dec 02, 2025, CELC was given a Buy rating by Maury Raycroft, with a target price of 134. The stock traded sideways with a 2.48% move, keeping the bullish thesis unresolved.

AUPH

Buy

Nov 07, 2025

Target

$21.00

Current

$15.82

Performance

8.28%

AUPH received a Buy rating from Maury Raycroft on Nov 07, 2025, aiming for 21. Momentum has favored the Buy call, with shares climbing from 15.82 to 15.82, rewarding those who trusted the recommendation.

OPK

Hold

Oct 31, 2025

Target

$1.60

Current

$1.30

Performance

-4.41%

On Oct 31, 2025, Maury Raycroft published a Hold outlook on OPK, with a target of 1.6. Sideways action left the Hold view intact, with no major move since 1.3.

ALNY

Buy

Oct 30, 2025

Target

$549.00

Current

$397.25

Performance

-11.64%

Maury Raycroft on Oct 30, 2025 assigned ALNY a Buy rating, with a price target of 549. The call has struggled to gain traction, with shares losing 11.64%.

KZR

Hold

Oct 17, 2025

Target

$7.00

Current

$6.26

Performance

-1.57%

On Oct 17, 2025, Maury Raycroft reaffirmed KZR with a Hold rating, targeting 7. The neutral call matched muted market action of -1.57%.

KOD

Buy

Sep 22, 2025

Target

$15.00

Current

$27.95

Performance

86.21%

KOD was rated Buy by Maury Raycroft on Sep 22, 2025, with a price objective of 15. A bullish response from the market helped close the gap of -12.95 to the target.

CRDF

Hold

Jun 24, 2025

Target

$3.50

Current

$2.87

Performance

-10.31%

On Jun 24, 2025, Maury Raycroft initiated coverage on CRDF with a Hold rating and target of 3.5. The rating matched the stock’s inability to hold above 2.87.

CRBP

Buy

Mar 11, 2025

Target

$53.00

Current

$8.01

Performance

16.42%

Maury Raycroft issued a Buy recommendation for CRBP on Mar 11, 2025, price target set at 53. Investors following the Buy call captured upside momentum, with shares now at 8.01.

CMRX

Hold

Mar 05, 2025

Target

$8.50

Current

$8.54

Performance

0.95%

On Mar 05, 2025, CMRX was evaluated by Maury Raycroft, who gave a Hold rating and target of 8.5. Hold sentiment was validated by subdued trading with no breakout beyond 8.54.

CMPX

Buy

Feb 10, 2025

Target

$8.00

Current

$5.38

Performance

37.95%

Maury Raycroft rated CMPX as Buy on Feb 10, 2025, setting a price target of 8. The call has proven timely, with shares rising 37.95% toward the price target of 8.

SGMO

Buy

Dec 31, 2024

Target

$3.00

Current

$0.43

Performance

-58.11%

On Dec 31, 2024, SGMO was given a Buy rating by Maury Raycroft, with a target price of 3. Despite the Buy call, shares fell from 0.4273 to 0.4273, challenging the optimistic stance.

ERAS

Buy

Nov 18, 2024

Target

$6.00

Current

$3.54

Performance

29.67%

ERAS received a Buy rating from Maury Raycroft on Nov 18, 2024, aiming for 6. Momentum has favored the Buy call, with shares climbing from 3.54 to 3.54, rewarding those who trusted the recommendation.

TNGX

Buy

Jul 17, 2024

Target

$19.00

Current

$8.63

Performance

-11.58%

On Jul 17, 2024, Maury Raycroft published a Buy outlook on TNGX, with a target of 19. Market action contradicted the Buy thesis, as shares slipped to 8.63.

CALT

Hold

May 28, 2024

Target

$39.00

Current

$40.00

Performance

5.40%

Maury Raycroft on May 28, 2024 assigned CALT a Hold rating, with a price target of 39. Shares outperformed expectations, climbing 5.40% despite the neutral view.

PRME

Buy

May 07, 2024

Target

$15.00

Current

$3.44

Performance

-38.24%

On May 07, 2024, Maury Raycroft reaffirmed PRME with a Buy rating, targeting 15. Shares slid 38.24% despite the recommendation, highlighting downside risks.

Frequency Asked Questions

Who is Maury Raycroft?

Maury Raycroft is an analyst from Jefferies specializing in the Healthcare sector.

What is Maury Raycroft's success rate?

Maury Raycroft currently has a success rate of +76.40%.

How many ratings has Maury Raycroft issued?

Maury Raycroft has issued 12 stock ratings so far.

What is the average return of Maury Raycroft's calls?

Their stock ratings have generated an average return of +56.77%.

What is Maury Raycroft's ranking?

Maury Raycroft is ranked #334 out of 4496 analysts.

What types of ratings does Maury Raycroft give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Maury Raycroft?

You can follow Maury Raycroft by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Maury Raycroft?

Their latest rating was a Hold on MREO issued on 2025-12-30.